|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 100 mM in water|
Preparing Stock Solutions
The following data is based on the product molecular weight 432.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.31 mL||11.56 mL||23.12 mL|
|5 mM||0.46 mL||2.31 mL||4.62 mL|
|10 mM||0.23 mL||1.16 mL||2.31 mL|
|50 mM||0.05 mL||0.23 mL||0.46 mL|
References are publications that support the products' biological activity.
Karhuvaara et al (1989) β-Adrenoceptor antagonist activities and binding affinities of timolol enantiomers in rat atria. J.Pharm.Pharmacol. 41 649 PMID: 2573714
If you know of a relevant reference for (S)-Timolol maleate, please let us know.
View Related Products by Product Action
Keywords: (S)-Timolol maleate, supplier, α1-adrenoceptor, beta1-adrenoceptor, b1-adrenoceptor, β1-Adrenergic, beta1-Adrenergic, b1-adrenergic, antagonists, receptors, β-blockers, beta-blockers, Adrenergic, Beta-1, Receptors, Adrenergic, Beta-1, Receptors, Tocris Bioscience
Citations for (S)-Timolol maleate
Citations are publications that use Tocris products.
Currently there are no citations for (S)-Timolol maleate. Do you know of a great paper that uses (S)-Timolol maleate from Tocris? If so please let us know.
Reviews for (S)-Timolol maleate
There are currently no reviews for this product. Be the first to review (S)-Timolol maleate and earn rewards!
Have you used (S)-Timolol maleate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.